Skip to main content
SP5007,799.88+0.66%DOW53,825.61+0.10%NASDAQ26,818.64+0.87%BTC$63,362.00+0.11%ETH$1,884.81+0.29%GOLD$4,407.70-1.34%OIL$81.23-2.45%
Smart Investors Daily
Sign InSign Up Free
Scilex Holding Company logo

NASDAQ · SCLX

Scilex Holding Company

Healthcare · Drug Manufacturers - General

$6.90

Down-$0.17 (-2.46%)

Updated Aug 13, 2026, 7:45 PM

SID Score

3.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
144.1M
P/E ratio
-0.52
Dividend yield
0.00%
52-week range
$4.20 – $34.27
Volume
49.61K
Avg. volume
202.34K

Price performance

SCLX price history

1M range · 21 trading sessions · Daily adjusted prices

SCLX closed at $6.90 after 21 trading sessions, down 25.16% for the selected period.

Last close
$6.90
Period change
-25.16%
Period low
$6.47
Period high
$9.22
Daily close
View OHLC price history
SCLX OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 12, 2026$6.68$6.97$6.5401$6.9049.61K
Aug 11, 2026$6.64$6.82$6.57$6.7117.16K
Aug 10, 2026$6.95$7.05$6.69$6.6915.24K
Aug 7, 2026$6.90$7.24$6.90$6.9539.41K
Aug 6, 2026$6.49$6.97$6.4568$6.9465.42K
Aug 5, 2026$6.55$6.68$6.3002$6.5249.49K
Aug 4, 2026$6.62$6.80$6.25$6.4774.42K
Aug 3, 2026$6.55$6.935$6.55$6.5631.34K
Jul 31, 2026$6.82$6.88$6.44$6.665100.04K
Jul 30, 2026$6.56$6.98$6.50$6.60112.08K
Jul 29, 2026$6.91$7.15$6.55$6.56100.63K
Jul 28, 2026$7.00$7.07$6.66$6.82112.13K
Jul 27, 2026$6.85$7.26$6.725$7.03120.14K
Jul 24, 2026$7.42$7.42$6.70$6.84128.89K
Jul 23, 2026$7.02$7.43$6.89$7.3959.21K
Jul 22, 2026$7.80$7.935$6.91$7.0382.12K
Jul 21, 2026$7.76$8.095$7.5101$7.8479.04K
Jul 20, 2026$8.49$8.51$7.57$7.64144.86K
Jul 17, 2026$8.37$8.91$8.13$8.44105.19K
Jul 16, 2026$9.00$9.48$8.65$8.7930.89K
Jul 15, 2026$8.78$9.3862$8.52$9.2252.15K

Latest SCLX news

The latest Smart Investors Daily articles mentioning SCLX.

Stock researchCompany · Overview

SCLX research

Overview

Company profile and research snapshot.

Company profile

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
SCLX recent ratings
DateFirmRatingTarget
Apr 11, 2025D. Boral CapitalHold—
Apr 2, 2025D. Boral CapitalBuy—
Feb 28, 2025D. Boral CapitalBuy—
Jan 27, 2025D. Boral CapitalBuy—
Oct 21, 2024HC Wainwright & Co.Buy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jul 7, 2026

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP

PALO ALTO, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR) , a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies, today announced the signing of a binding term sheet with iHolding Group LLP (“iHolding”), a private investment group headquartered in Almaty, Republic of Kazakhstan. The term sheet contemplates that iHolding will purchase $100,000,000 o

Yahoo · Jul 6, 2026

Scilex Shares Jump After Securing $100 Million Strategic Investment Proposal (SCLX)

Binding Term Sheet Supports Growth PlansScilex Holding Company (NASDAQ:SCLX) shares climbed 7% on Monday after the company announced it had signed a binding term sheet for a proposed $100 million strategic investment from Kazakhstan-based private investment firm iHolding Group LLP. Under the proposed agreement, iHolding would acquire approximately 6.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By